Literature DB >> 1905204

Treatment of cutaneous leishmaniasis using a carbon dioxide laser.

K B Babajev1, O G Babajev, V I Korepanov.   

Abstract

Use of a carbon dioxide laser to vaporize the local lesions caused by cutaneous leishmaniasis is reported. A total of 108 patients have been treated in this way and followed up. The treatment reduces the management time of patients at least 1.5 times and is followed by satisfactory aesthetic outcomes. No recurrences have been observed among the 82 patients who have been followed up for 7 years.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1905204      PMCID: PMC2393224     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  5 in total

1.  Treatment of hidradenitis suppurativa with the carbon dioxide laser.

Authors:  J C Dalrymple; J M Monaghan
Journal:  Br J Surg       Date:  1987-05       Impact factor: 6.939

2.  Treatment of cutaneous leishmaniasis by curettage.

Authors:  M A Currie
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-15

3.  Cryosurgery for cutaneous leishmaniasis.

Authors:  W R Faber
Journal:  J Dermatol Surg Oncol       Date:  1983-05

4.  Cryosurgery in cutaneous leishmaniasis.

Authors:  A Bassiouny; M El Meshad; M Talaat; K Kutty; B Metawaa
Journal:  Br J Dermatol       Date:  1982-10       Impact factor: 9.302

5.  Cutaneous leishmaniasis: surgical management of a case with unusual clinical and histological features.

Authors:  S Barsky; W Storino; K Salgea; P Knapp
Journal:  Arch Dermatol       Date:  1978-09
  5 in total
  7 in total

Review 1.  Interventions for Old World cutaneous leishmaniasis.

Authors:  Julio Heras-Mosteiro; Begoña Monge-Maillo; Mariona Pinart; Patricia Lopez Pereira; Ludovic Reveiz; Emely Garcia-Carrasco; Pedro Campuzano Cuadrado; Ana Royuela; Irene Mendez Roman; Rogelio López-Vélez
Journal:  Cochrane Database Syst Rev       Date:  2017-11-17

2.  Successful treatment of lupoid cutaneous leishmaniasis with glucantime and topical trichloroacetic acid (a case report).

Authors:  Mohamad Ali Nilforoushzadeh; Giti Sadeghian; Fariba Jaffary; Hengameh Ziaei; Liela Shirani-Bidabad; Parvin Mahzoni
Journal:  Korean J Parasitol       Date:  2008-09       Impact factor: 1.341

Review 3.  Interventions for Old World cutaneous leishmaniasis.

Authors:  Julio Heras-Mosteiro; Begoña Monge-Maillo; Mariona Pinart; Patricia Lopez Pereira; Ludovic Reveiz; Emely Garcia-Carrasco; Pedro Campuzano Cuadrado; Ana Royuela; Irene Mendez Roman; Rogelio López-Vélez
Journal:  Cochrane Database Syst Rev       Date:  2017-12-01

4.  A randomized controlled phase IIb wound healing trial of cutaneous leishmaniasis ulcers with 0.045% pharmaceutical chlorite (DAC N-055) with and without bipolar high frequency electro-cauterization versus intralesional antimony in Afghanistan.

Authors:  Hans-Christian Stahl; Faridullah Ahmadi; Ulrike Schleicher; Rainer Sauerborn; Justo Lorenzo Bermejo; Mohammed Latif Amirih; Ibrahim Sakhayee; Christian Bogdan; Kurt-Wilhelm Stahl
Journal:  BMC Infect Dis       Date:  2014-11-25       Impact factor: 3.090

5.  The effect of Nd:YAG laser therapy on cutaneous leishmaniasis compared to intralesional meglumine antimoniate.

Authors:  Mohammad Omidian; Maryam Jadbabaei; Ehsan Omidian; Zahra Omidian
Journal:  Postepy Dermatol Alergol       Date:  2019-02-20       Impact factor: 1.837

6.  Rapid healing of cutaneous leishmaniasis by high-frequency electrocauterization and hydrogel wound care with or without DAC N-055: a randomized controlled phase IIa trial in Kabul.

Authors:  Ahmad Fawad Jebran; Ulrike Schleicher; Reto Steiner; Pia Wentker; Farouq Mahfuz; Hans-Christian Stahl; Faquir Mohammad Amin; Christian Bogdan; Kurt-Wilhelm Stahl
Journal:  PLoS Negl Trop Dis       Date:  2014-02-13

7.  A Comparison between the Effects of Glucantime, Topical Trichloroacetic Acid 50% plus Glucantime, and Fractional Carbon Dioxide Laser plus Glucantime on Cutaneous Leishmaniasis Lesions.

Authors:  Fariba Jaffary; Mohammad Ali Nilforoushzadeh; Amirhossein Siadat; Elaheh Haftbaradaran; Nazli Ansari; Elham Ahmadi
Journal:  Dermatol Res Pract       Date:  2016-04-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.